Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
Authors
Keywords
-
Journal
Stem Cells International
Volume 2020, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2020-02-04
DOI
10.1155/2020/6574010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway
- (2019) Xiaoli Rong et al. Stem Cell Research & Therapy
- Approaches and Methods to Measure Oxidative Stress in Clinical Samples: Research Applications in the Cancer Field
- (2019) Meghri Katerji et al. Oxidative Medicine and Cellular Longevity
- Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy
- (2019) Tariq Hussain et al. Cells
- Mesenchymal stem cells and their conditioned medium can enhance the repair of uterine defects in a rat model
- (2018) Chi-Hong Ho et al. Journal of the Chinese Medical Association
- The Effects of Conditioned Medium Derived from Mesenchymal Stem Cells Cocultured with Hepatocytes on Damaged Hepatocytes and Acute Liver Failure in Rats
- (2018) Li Chen et al. Stem Cells International
- Simple spectrophotometric assay for measuring catalase activity in biological tissues
- (2018) Mahmoud Hussein Hadwan BMC BIOCHEMISTRY
- Mesenchymal Stem Cells and Induced Bone Marrow-Derived Macrophages Synergistically Improve Liver Fibrosis in Mice
- (2018) Yusuke Watanabe et al. Stem Cells Translational Medicine
- Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis
- (2016) Shu Dong et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Stem Cell-Derived Exosomes: A Potential Alternative Therapeutic Agent in Orthopaedics
- (2016) John Burke et al. Stem Cells International
- New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials
- (2016) Kai Qu et al. Frontiers in Pharmacology
- Effective Prevention of Liver Fibrosis by Liver-targeted Hydrodynamic Gene Delivery of Matrix Metalloproteinase-13 in a Rat Liver Fibrosis Model
- (2016) Hiroyuki Abe et al. Molecular Therapy-Nucleic Acids
- Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: An insight
- (2014) Gamal E Shiha et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- The Effect of Conditioned Media of Adipose-Derived Stem Cells on Wound Healing after Ablative Fractional Carbon Dioxide Laser Resurfacing
- (2013) Bing-Rong Zhou et al. Biomed Research International
- Clinical evidence for the regression of liver fibrosis
- (2012) Elizabeth L. Ellis et al. JOURNAL OF HEPATOLOGY
- Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression
- (2011) Mohamed E. Shaker et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib
- (2011) Yuqing Liu et al. JOURNAL OF HEPATOLOGY
- Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis
- (2011) Mohamed E. Shaker et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started